Healthcare provider profile · identity verified

Norr Hashem, D.O.

Family Practice · POWNAL, VT · NPI 1760778724

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	524	139
Lisinopril	Lisinopril	456	133
Omeprazole	Omeprazole	353	100
Gabapentin	Gabapentin	321	97
Amlodipine Besylate	Amlodipine Besylate	311	85
Levothyroxine Sodium	Levothyroxine Sodium	273	75
Losartan Potassium	Losartan Potassium	248	74
Metoprolol Succinate	Metoprolol Succinate	228	55
Metformin Hcl	Metformin Hcl	226	68
Albuterol Sulfate Hfa	Albuterol Sulfate	223	77
Tamsulosin Hcl	Tamsulosin Hcl	212	65
Hydrochlorothiazide	Hydrochlorothiazide	195	64
Simvastatin	Simvastatin	184	48
Famotidine	Famotidine	179	51
Pravastatin Sodium	Pravastatin Sodium	172	47
Pantoprazole Sodium	Pantoprazole Sodium	159	39
Fluticasone Propionate	Fluticasone Propionate	151	80
Chlorthalidone	Chlorthalidone	150	34
Sertraline Hcl	Sertraline Hcl	149	36
Trazodone Hcl	Trazodone Hcl	143	43
Trulicity	Dulaglutide	139	23
Eliquis	Apixaban	131	30
Lorazepam	Lorazepam	130	31
Ozempic	Semaglutide	118	28
Atenolol	Atenolol	116	28
Duloxetine Hcl	Duloxetine Hcl	116	24
Furosemide	Furosemide	114	40
Potassium Chloride	Potassium Chloride	114	19
Metoprolol Tartrate	Metoprolol Tartrate	108	33
Allopurinol	Allopurinol	103	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	96	31
Rosuvastatin Calcium	Rosuvastatin Calcium	89	29
Prednisone	Prednisone	86	61
Pregabalin	Pregabalin	86	20
Finasteride	Finasteride	81	19
Montelukast Sodium	Montelukast Sodium	79	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	78	68
Citalopram Hbr	Citalopram Hydrobromide	76	20
Clopidogrel	Clopidogrel Bisulfate	75	23
Escitalopram Oxalate	Escitalopram Oxalate	73	16
Tramadol Hcl	Tramadol Hcl	72	27
Jardiance	Empagliflozin	67	16
Warfarin Sodium	Warfarin Sodium	67	17
Ventolin Hfa	Albuterol Sulfate	64	20
Glipizide	Glipizide	63	22
Doxycycline Hyclate	Doxycycline Hyclate	59	46
Ropinirole Hcl	Ropinirole Hcl	56	12
Ibuprofen	Ibuprofen	54	16
Metformin Hcl Er	Metformin Hcl	52	16
Alprazolam	Alprazolam	50	suppressed
Nystatin	Nystatin	50	24
Carvedilol	Carvedilol	47	16
Diclofenac Sodium	Diclofenac Sodium	46	22
Lamotrigine	Lamotrigine	46	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	18
Torsemide	Torsemide	46	13
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	45	suppressed
Farxiga	Dapagliflozin Propanediol	44	suppressed
Glimepiride	Glimepiride	43	13
Breo Ellipta	Fluticasone/Vilanterol	42	suppressed
Donepezil Hcl	Donepezil Hcl	42	suppressed
Januvia	Sitagliptin Phosphate	42	suppressed
Lovastatin	Lovastatin	42	suppressed
Mounjaro	Tirzepatide	40	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	40	28
Valacyclovir	Valacyclovir Hcl	40	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	39	15
Venlafaxine Hcl Er	Venlafaxine Hcl	39	12
Azithromycin	Azithromycin	38	34
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Bupropion Hcl Sr	Bupropion Hcl	37	11
Fluoxetine Hcl	Fluoxetine Hcl	37	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	14
Aripiprazole	Aripiprazole	36	suppressed
Ondansetron Odt	Ondansetron	36	23
Oxycodone Hcl	Oxycodone Hcl	36	13
Celecoxib	Celecoxib	35	suppressed
Risperidone	Risperidone	35	suppressed
Buspirone Hcl	Buspirone Hcl	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Spironolactone	Spironolactone	32	suppressed
Alendronate Sodium	Alendronate Sodium	31	11
Clonazepam	Clonazepam	31	suppressed
Glipizide Er	Glipizide	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Bupropion Xl	Bupropion Hcl	30	17
Cephalexin	Cephalexin	30	30
Temazepam	Temazepam	30	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Arnuity Ellipta	Fluticasone Furoate	28	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Olanzapine	Olanzapine	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	11
Divalproex Sodium Er	Divalproex Sodium	25	suppressed
Ranolazine Er	Ranolazine	25	suppressed
Meloxicam	Meloxicam	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Sildenafil Citrate	Sildenafil Citrate	22	suppressed
Baclofen	Baclofen	21	17
Loperamide	Loperamide Hcl	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Fluconazole	Fluconazole	18	15
Methadone Hcl	Methadone Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	18
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Carbamazepine Er	Carbamazepine	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	12
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Valsartan	Valsartan	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Oxcarbazepine	Oxcarbazepine	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Clonidine Hcl Er	Clonidine Hcl	14	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Naltrexone Hcl	Naltrexone Hcl	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Cefdinir	Cefdinir	13	12
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Nurtec Odt	Rimegepant Sulfate	11	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed
Vesicare	Solifenacin Succinate	11	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error